Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.700
-0.090 (-1.88%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Champions Oncology Market Cap
Champions Oncology has a market cap or net worth of $65.42 million as of October 16, 2026. It is the 28,313th most valuable company in the world and the 4,447th biggest in the United States. Its market cap has decreased by 27.88% in one year.
Market Cap
65.42M
Enterprise Value
72.03M
1-Year Change
-27.88%
Global Rank
Country Rank
#4,447 United States
Category
ChartMarket Cap Chart
Since August 21, 2015, Champions Oncology's market cap has increased from $45.90M to $65.42M, an increase of 42.52%. That is a compound annual growth rate of 3.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 65.40M | -31.88% |
| Dec 31, 2025 | 96.00M | -18.92% |
| Dec 31, 2024 | 118.40M | 54.97% |
| Dec 29, 2023 | 76.40M | 25.04% |
| Dec 30, 2022 | 61.10M | -45.93% |
| Dec 31, 2021 | 113.00M | -21.69% |
| Dec 31, 2020 | 144.30M | 49.07% |
| Dec 31, 2019 | 96.80M | 8.04% |
| Dec 31, 2018 | 89.60M | 110.33% |
| Dec 29, 2017 | 42.60M | 53.79% |
| Dec 30, 2016 | 27.70M | -10.93% |
| Dec 31, 2015 | 31.10M | -32.24% |
| Aug 21, 2015 | 45.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Heron Therapeutics | 68.54M |
| NeOnc Technologies Holdings | 67.11M |
| MAIA Biotechnology | 66.91M |
| XBiotech | 64.63M |
| Spero Therapeutics | 64.06M |
| Oncolytics Biotech | 63.51M |
| Cingulate | 63.40M |
| Biomea Fusion | 62.98M |